AI assistant
Sending…
Glenmark Pharmaceuticals ltd — Share Issue/Capital Change 2018
Nov 13, 2018
62608_rns_2018-11-13_33d2ac40-402b-4089-b468-1f1a3254cb4b.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
==> picture [131 x 63] intentionally omitted <==
| pursuanttoEmployee Stock Options | Scheme, 2016: |
|---|---|
| NumberofOptions Granted | 20,000 OptionsEachOption represents 1 EquitysharesofRe.1each |
| NumberofOrdinarysharescovered under the Optionsgranted | 20,000 equity sharesofRe.1each |
| Vesting periodr | Tocommence after a periodofone year from thedateofthe grant and extend upto a maximum periodofsixyears from the dateofthegrant |
| Exercise Period | Tocommence from the dateofvestingofstockoptionsandmayextend till the expiry ofthe scheme |
| Exercise Price | Rs.600per Option |
More from Glenmark Pharmaceuticals ltd
Investor Presentation
2026
May 29
Investor Presentation
2026
May 29
Earnings Release
2026
May 29
Earnings Release
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 29
Board/Management Information
2026
May 29
Interim / Quarterly Report
2026
May 29